Considerations for powering a clinical proteomics study: Normal variability in the human plasma proteome

Proteomics - Clinical Applications

Volumn 3, Issue 3, 2009, Pages 394-407

  Jackson, David ^a,c   Herath, Athula ^a   Swinton, Jonathan ^a   Bramwell, David ^b   Chopra, Rajesh ^a   Hughes, Andrew ^a   Cheeseman, Kevin ^a   Tonge, Robert ^a,c  

^a ASTRAZENECA   (United Kingdom)

^b Nonlinear Dynamics   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

2 D DIGE; Image analysis; Plasma; Statistical power; Variability

Indexed keywords

PLASMA PROTEIN; PROTEOME;

ADULT; ARTICLE; BATCH PROCESS; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; PLASMA; POWER ANALYSIS; PRIORITY JOURNAL; PROCESS TECHNOLOGY; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SAMPLE SIZE; SENSITIVITY ANALYSIS; TWO DIMENSIONAL DIFFERENTIAL GEL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 65549116582     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800066     Document Type: Article

References (40)

1. Chen, G., Gharib, T. G., Wang, H., Huang, C. C. et al., Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl. Acad. Sci. USA 2003, 100, 13537-13542.
2. Cho, W. C., Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer 2007, 6, 25.
3. Okano, T., Kondo, T., Fujii, K., Nishimura, T. et al., Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin. Cancer Res. 2007, 13, 799-805.
4. Cho, W. C., Yip, T. T., Yip, C., Yip, V. et al., Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res. 2004, 10, 43-52.
5. Papadopoulos, M. C., Abel, P. M., Agranoff, D., Stich, A. et al., A novel and accurate diagnostic test for human African trypanosomiasis. Lancet 2004, 363, 1358-1363.
6. Agranoff, D., Fernandez-Reyes, D., Papadopoulos, M. C., Rojas, S. A. et al., Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368, 1012-1021.
7. Horgan, G. W., Sample size and replication in 2D gel electrophoresis studies. J. Proteome Res. 2007, 6, 2884-2887.
8. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1, 377-396.
9. Shaw, J., Rowlinson, R., Nickson, J., Stone, T. et al., Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics 2003, 3, 1181-1195.
10. Alban, A., David, S. O., Bjorkesten, L., Andersson, C. et al., A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3, 36-44.
11. Görg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
12. Karp, N. A., Kreil, D. P., Lilley, K. S., Determining a significant change in protein expression with DeCyder during a pairwise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004, 4, 1421-1432.
13. Karp, N. A., Spencer, M., Lindsay, H., O'Dell, K., Lilley, K. S., Impact of replicate types on proteomic expression analysis. J. Proteome Res. 2005, 4, 1867-1871.
14. Karp, N. A., Lilley, K. S., Maximising sensitivity for detecting changes in protein expression: Experimental design using minimal CyDyes. Proteomics 2005, 5, 3105-3115.
15. Karp, N. A., McCormick, P. S., Russell, M. R., Lilley, K. S., Experimental and statistical considerations to avoid false conclusions in proteomic studies using differential in-gel electrophoresis. Mol. Cell. Proteomics 2007, 6, 1354-1364.
16. Anderson, N. L., Anderson, N. G., The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
17. Miller, J. C., Zhou, H., Kwekel, J., Cavallo, R. et al., Antibody microarray profiling of human prostate cancer sera: Anti-body screening and identification of potential biomarkers. Proteomics 2003, 3, 56-63.
18. Juan, H. F., Chen, J. H., Hsu, W. T., Huang, S. C. et al., Identification of tumor-associated plasma biomarkers using proteomic techniques: From mouse to human. Proteomics 2004, 4, 2766-2775.
19. Ahmed, N., Oliva, K. T., Barker, G., Hoffmann, P. et al., Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics 2005, 5, 4625-4636.
20. Ang, I. L., Poon, T. C., Lai, P. B., Chan, A. T. et al., Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: A glycoproteomic approach. J. Proteome Res. 2006, 5, 2691-2700.
21. Jackson, D., Craven, R. A., Hutson, R. C., Graze, I. et al., Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer. Clin. Cancer Res. 2007, 13, 7370-7379.
22. Li, X., Gong, Y., Wang, Y., Wu, S. et al., Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics 2005, 5, 3423-3441.
23. Gong, Y., Li, X., Yang, B., Ying, W. et al., Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 2006, 5, 1379-1387.
24. Liu, T., Qian, W. J., Mottaz, H. M., Gritsenko, M. A. et al., Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol. Cell. Proteomics 2006, 5, 2167-2174.
25. Echan, L. A., Tang, H. Y., Ali-Khan, N., Lee, K., Speicher, D. W., Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005, 5, 3292-3303.
26. Gundry, R. L., Fu, Q., Jelinek, C. A., Van Eyk, J. E., Cotter, R. J., Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin. Appl. 2007, 1, 73-88.
27. Hunt, S. M., Thomas, M. R., Sebastian, L. T., Pedersen, S. K. et al., Optimal replication and the importance of experimental design for gel-based quantitative proteomics. J. Proteome Res. 2005, 4, 809-819.
28. Hu, Y., Malone, J. P., Fagan, A. M., Townsend, R. R., Holtzman, D. M., Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. Mol. Cell. Proteomics 2005, 4, 2000-2009.
29. Nedelkov, D., Kiernan, U. A., Niederkofler, E. E., Tubbs, K. A., Nelson, R. W., Investigating diversity in human plasma proteins. Proc. Natl. Acad. Sci. USA 2005, 102, 10852-10857.
30. Nedelkov, D., Phillips, D. A., Tubbs, K. A., Nelson, R. W., Investigation of human protein variants and their frequency in the general population. Mol. Cell. Proteomics 2007, 6, 1183-1187.
31. Corzett, T. H., Fodor, I. K., Choi, M. W., Walsworth, V. L. et al., Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis. J. Proteome Res. 2006, 5, 2611-2619.
32. Terry, D. E., Desiderio, D. M., Between-gel reproducibility of the human cerebrospinal fluid proteome. Proteomics 2003, 3, 1962-1979.
33. Neuhoff, V., Stamm, R., Eibl, H., Clear background and highly sensitive protein staining with Coomassie blue dyes in polyacrylamide gels: A systematic analysis. Electrophoresis 1985, 6, 427-448.
34. Blum, H., Beier, H., Gross, H. J., Improved silver staining of plant proteins, RNA, and DNA in polyacrylamide gels. Electrophoresis 1987, 8, 93-99.
35. Neuhoff, V., Arold, N., Taube, D., Ehrhardt, W., Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie brilliant blue G-250 and R-250. Electrophoresis 1988, 9, 255-262.
36. R Development Core Team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria 2007. http://www.R-project.org.
37. Warnes, G. R., Liu, P., Sample Size Estimation for Microarray Experiments. Technical Report 06/06. Department of Biostatistics and Computational Biology, University of Rochester, Rochester 2006.
38. Warnes, G. R., Lie, P., Li, F., Estimate Microarray Sample Size, SSIZE (Version 1.6.0). 2007 (http://bioconductor.org/packages/1.9/bioc/ html/ssize.html).
39. Adkins, J. N., Monroe, M. E., Auberry, K. J., Shen, Y. et al., A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategy. Proteomics 2005, 5, 3454-3466.
40. Rai, A. J., Gelfand, C. A., Haywood, B. C., Warunek, D. J. et al., HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5, 3262-3277.